Skip to Content

par 545 (Ranitidine Hydrochloride 300 mg)

Pill with imprint par 545 is Yellow, Elliptical / Oval and has been identified as Ranitidine Hydrochloride 300 mg. It is supplied by Par Pharmaceutical Inc..

Ranitidine is used in the treatment of duodenal ulcer; duodenal ulcer prophylaxis; erosive esophagitis; gerd; cutaneous mastocytosis and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for par 545

Ranitidine hydrochloride 300 mg par 545  Front
Ranitidine hydrochloride 300 mg par 545  Back
Ranitidine hydrochloride 300 mg par 545
Ranitidine hydrochloride 300 mg par 545

Ranitidine Hydrochloride

Imprint:
par 545
Strength:
300 mg
Color:
Yellow
Size:
14.00 mm
Shape:
Elliptical / Oval
Availability:
Rx and/or OTC
Drug Class:
H2 antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Par Pharmaceutical Inc.
National Drug Code (NDC):
49884-0545
Inactive Ingredients:

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide